Clinical applications of prostaglandins and their inhibitors.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000378:metabolism; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology; D008881:Migraine Disorders / Q000188:drug therapy / Q000209:etiology; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011464:Epoprostenol